3-187838904-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000793661.1(ENSG00000303324):​n.344-5363C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.445 in 149,318 control chromosomes in the GnomAD database, including 16,770 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16770 hom., cov: 28)

Consequence

ENSG00000303324
ENST00000793661.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.962

Publications

3 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000793661.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.692 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000793661.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000303324
ENST00000793661.1
n.344-5363C>G
intron
N/A
ENSG00000303324
ENST00000793662.1
n.601-22834C>G
intron
N/A
ENSG00000303324
ENST00000793663.1
n.616+38103C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.445
AC:
66450
AN:
149200
Hom.:
16746
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.699
Gnomad AMI
AF:
0.284
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.311
Gnomad EAS
AF:
0.288
Gnomad SAS
AF:
0.331
Gnomad FIN
AF:
0.375
Gnomad MID
AF:
0.372
Gnomad NFE
AF:
0.361
Gnomad OTH
AF:
0.408
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.445
AC:
66513
AN:
149318
Hom.:
16770
Cov.:
28
AF XY:
0.440
AC XY:
31960
AN XY:
72618
show subpopulations
African (AFR)
AF:
0.698
AC:
28566
AN:
40902
American (AMR)
AF:
0.313
AC:
4614
AN:
14764
Ashkenazi Jewish (ASJ)
AF:
0.311
AC:
1067
AN:
3436
East Asian (EAS)
AF:
0.287
AC:
1449
AN:
5040
South Asian (SAS)
AF:
0.332
AC:
1517
AN:
4564
European-Finnish (FIN)
AF:
0.375
AC:
3800
AN:
10124
Middle Eastern (MID)
AF:
0.376
AC:
109
AN:
290
European-Non Finnish (NFE)
AF:
0.361
AC:
24294
AN:
67236
Other (OTH)
AF:
0.409
AC:
839
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.564
Heterozygous variant carriers
0
1479
2957
4436
5914
7393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.284
Hom.:
725
Bravo
AF:
0.450

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.48
DANN
Benign
0.32
PhyloP100
-0.96

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2611611;
hg19: chr3-187556692;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.